Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation
Keywords: Carboxyamidotriazole; Inflammatory bowel disease; TNBS rat colitis; NLRP3 inflammasome; NF-κB;